Ipratropium Bromide in Peri-Operative COPD

Summary

This is a randomized, double-blind, placebo-controlled, parallel-group, multi-centre trial.The trial aims to evaluate efficacy of nebulized ipratropium bromide in Chinese peri-operative patients with COPD under general anaesthesia.

Timeline

Start

2013-10

Primary completion

2015-07

Completion

2015-08

Outcome

Met primary endpoint

registry Nebulized Ipratropium Bromide vs Placebo; p <0.0001; Mean Difference (Net) 154.9 (95% CI 91.08 to 218.63); ANCOVA NCT01943552 ↗

Drugs

Indications